recommended for detection of AF9 of human origin by WB, IP and ELISA
Modification Notes
The MLL (ALL-1, HRX) gene influences myelomonocytic differentiation, and different chromosomal translocations can result in a range of MLL fusion proteins that mediate leukemia. Frequent translocation partners of MLL include ELL, ENL, AF4, AF6 and AF9. ELL (elongation factor RNA polymerase II, Men) encodes an RNA polymerase II elongation factor that is implicated in t(11;19)(q23;p13.1) translocation in myeloid leukemias. AF9 (MLLT3, YEATS3) fusion with the MLL gene results in a t[(9;11)(p22;q23)] translocation, which is associated with de novo acute myelogenous leukemia (AML). ENL (MLLT1, LTG19, YEATS1, eleven-nineteen leukemia protein) is capable of activating transcription from synthetic reporter genes in both lymphoid and myeloid cells. The t[(11;19) (q23;p13)] translocation results in the MLL-ENL fusion protein, which is commonly found in infant acute leukemias of both the myeloid and lymphoid lineage.
Key Feature
Clonality
Polyclonal
Isotype
IgG
Host Species
Rabbit
Tested Applications
WBIPELISA
WB:1:500~1:2000 IP:1:100~1:500 Notes:Optimal dilutions/concentrations should be determined by the researcher.
Species Reactivity
HumanMouseRat
Concentration
1mg/ml
Purification
Affinity purified
Target Information
Alternative Names
recommended for detection of AF9 of human origin by WB IP and ELISA
Tissue Specificity
recommended for detection of AF9 of human origin by WB, IP and ELISA